VYGRNasdaq United States
Market cap
$197.578 M
$3.27 +4.47%
Close of 7 Aug 2026
Revenue
$40.4M
#2809 by revenue
Earnings
-$119.7M
Loss-making
Shares outstanding
61,617,948
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Voyager Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.